Variations of serum IgG subclass levels in hepatitis C virus infection during interferon-alpha therapy

被引：5
|
作者：
Musset, L
Ghillani, P
Lunel, F
Cacoub, P
Cresta, P
Frangeul, L
Rosenheim, M
Preudhomme, JL
机构：
[1] GRP HOSP PITIE SALPETRIERE,VIROL LAB,F-75651 PARIS 13,FRANCE
[2] GRP HOSP PITIE SALPETRIERE,DEPT HEPATOGASTROENTEROL,F-75651 PARIS 13,FRANCE
[3] GRP HOSP PITIE SALPETRIERE,DEPT INTERNAL MED,F-75651 PARIS 13,FRANCE
[4] GRP HOSP PITIE SALPETRIERE,PUBL HLTH UNIT,F-75651 PARIS 13,FRANCE
[5] UNIV POITIERS HOSP,LAB IMMUNOL & IMMUNOPATHOL,CNRS URA 1172,POITIERS,FRANCE
来源：
IMMUNOLOGY LETTERS | 1997年 / 55卷 / 01期
关键词：
hepatitis C virus; IgG subclass; interferon-alpha;
D O I：
10.1016/S0165-2478(96)02681-8
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Serum IgG1 levels are selectively increased in patients with chronic hepatitis C virus (HCV) infection. In 15 patients who received interferon (IFN)-alpha therapy, serum levels of immunoglobulin classes and IgG subclasses were measured during treatment and after it was discontinued. In spite of important individual variations, mean IgG, IgG1, IgA and IgM levels decreased during therapy and tended to return to pre-treatment levels afterwards, with no detectable correlation with clinical and biological parameters. These results suggest an effect of IFN-alpha on in vivo immunoglobulin production, in HCV carriers. (C) 1997 Elsevier Science B.V.
引用
收藏
页码：41 / 45
页数：5
相关论文
共 50 条
  • [1] Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection
    Willems, M
    Munte, K
    Vrolijk, JM
    Den Hollander, JC
    Böhm, M
    Kemmeren, MH
    De Man, RA
    Brouwer, JT
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (02) : 390 - 394
  • [2] Systemic sarcoidosis during interferon-alpha therapy for chronic hepatitis C virus infection
    Cacoub, P
    Sbaï, A
    Francès, C
    Génesti, C
    Hausfater, P
    Piette, JC
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2000, 24 (03): : 364 - 366
  • [3] Interferon-alpha suppresses leptin levels: Studies in interferon-alpha treated patients with hepatitis C virus infection and murine adipocytes
    Kaser, S
    Kaser, A
    Vogel, W
    Patsch, JR
    Tilg, H
    EUROPEAN CYTOKINE NETWORK, 2002, 13 (02) : 225 - 229
  • [4] Interferon-alpha and hepatitis C virus: the skin matters
    Floristan, U.
    Feltes, R.
    Ramirez-Marin, P.
    Herranz-Pinto, P.
    REVISTA CLINICA ESPANOLA, 2011, 211 (02): : 92 - 97
  • [5] Interferon-alpha treatment of chronic hepatitis C virus infection in children
    Jonas, MM
    Ott, MJ
    Nelson, SP
    Badizadegan, K
    Perez-Atayde, AR
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (03) : 241 - 246
  • [6] PRIMARY BILIARY-CIRRHOSIS INDUCED BY INTERFERON-ALPHA THERAPY FOR HEPATITIS-C VIRUS-INFECTION
    DAMICO, E
    PAROLI, M
    FRATELLI, V
    PALAZZI, C
    BARNABA, V
    CALLEA, F
    CONSOLI, G
    DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (10) : 2113 - 2116
  • [7] SERUM HYALURONATE LEVELS PREDICT RESPONSIVENESS TO INTERFERON-ALPHA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C
    MATSUNAGA, T
    KOJIMA, J
    INOUE, A
    MATSUMIYA, K
    CLINICA CHIMICA ACTA, 1994, 229 (1-2) : 191 - 195
  • [8] Conception and pregnancy during interferon-alpha therapy for chronic hepatitis C
    Trotter, JF
    Zygmunt, AJ
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 32 (01) : 76 - 78
  • [9] EFFECTS OF INTERFERON-ALPHA ON SERUM HEPATITIS-C VIRUS IN PATIENTS WITH CHRONIC HEPATITIS-C
    SHIBATA, M
    KUMADA, T
    YAMADA, M
    NAKANO, S
    KUDO, T
    MORISHIMA, T
    DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (04) : 608 - 611
  • [10] Enhanced Levels of Interleukin-8 Are Associated with Hepatitis B Virus Infection and Resistance to Interferon-Alpha Therapy
    Yang, Kai
    Guan, Shi-He
    Zhang, Hao
    Pan, Ying
    Wu, Yuan-Yuan
    Wang, Ai-Hua
    Sun, Bei-Bei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (11): : 21286 - 21298
12345